Investor Advocacy Investor Rights Class Action Lawsuits Investor Protection Fraud Awareness Health Claims Healthcare Services Healthcare Ethics Medical Ethics Financial Markets Digital Economy Education Access Plaintiffs Statutory Rights Investor Awareness Financial Transactions Digital Rights Incapacitation Litigation Trends Financial Compensation Securities Fraud Corporate Accountability Litigation Process Arbitration Dispute Resolution
Investors who bought JHX during the alleged May–August 2025 period face a December 23 cutoff to seek control of the case in Illinois federal court.